Mon, April 27, 2020
Fri, April 24, 2020
Thu, April 23, 2020
Wed, April 22, 2020
Tue, April 21, 2020

Difei Yang Maintained (XERS) at Strong Buy with Decreased Target to $14 on, Apr 23rd, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-14-on-apr-23rd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Difei Yang of Mizuho, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Decreased Target from $18 to $14 on, Apr 23rd, 2020.

Difei has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Difei's Rating of Hold.



This is the rating of the analyst that currently disagrees with Difei


  • David Amsellem of "Piper Sandler" Initiated at Buy and Held Target at $12 on, Tuesday, February 18th, 2020

Publication Contributing Sources